c-Src kinase;
3D-QSAR;
docking;
quinazolin derivatives;
receptor based alignment;
MOLECULAR-FORCE FIELD;
SRC/ABL KINASE INHIBITOR;
TYROSINE KINASE;
ABL KINASES;
ACCURATE DOCKING;
FAMILY KINASES;
HUMAN CANCER;
MMFF94;
4-PHENYLAMINO-3-QUINOLINECARBONITRILES;
RESISTANCE;
D O I:
10.1111/j.1747-0285.2009.00789.x
中图分类号:
Q5 [生物化学];
Q7 [分子生物学];
学科分类号:
071010 ;
081704 ;
摘要:
c-Src kinase play an important role in cell growth and differentiation and its inhibitors can be useful for the treatment of various diseases, including cancer, osteoporosis, and metastatic bone disease. Three dimensional quantitative structure-activity relationship (3D-QSAR) studies were carried out on quinazolin derivatives inhibiting c-Src kinase. Molecular field analysis (MFA) models with four different alignment techniques, namely, glide, gold, ligandfit and Least squares based methods were developed. glide based MFA model showed better results (Leave one out cross validation correlation coefficient r(cv)(2)= 0.923 and non-cross validation correlation coefficient r(2) = 0.958) when compared with other models. These results help us to understand the nature of descriptors required for activity of these compounds and thereby provide guidelines to design novel and potent c-Src kinase inhibitors.
机构:
Kitasato Univ, Sch Pharm, Minato Ku, Tokyo 1088641, Japan
Mitsubishi Tanabe Pharma Corp, DMPK Res Labs, Toda, Saitama 3358505, JapanKitasato Univ, Sch Pharm, Minato Ku, Tokyo 1088641, Japan
Kato, Harutoshi
Yamaotsu, Noriyuki
论文数: 0引用数: 0
h-index: 0
机构:
Kitasato Univ, Sch Pharm, Minato Ku, Tokyo 1088641, JapanKitasato Univ, Sch Pharm, Minato Ku, Tokyo 1088641, Japan
Yamaotsu, Noriyuki
Iwazaki, Norihiko
论文数: 0引用数: 0
h-index: 0
机构:
Mitsubishi Tanabe Pharma Corp, DMPK Res Labs, Toda, Saitama 3358505, JapanKitasato Univ, Sch Pharm, Minato Ku, Tokyo 1088641, Japan
Iwazaki, Norihiko
Okamura, Shigeaki
论文数: 0引用数: 0
h-index: 0
机构:
Mitsubishi Tanabe Pharma Corp, DMPK Res Labs, Toda, Saitama 3358505, JapanKitasato Univ, Sch Pharm, Minato Ku, Tokyo 1088641, Japan
Okamura, Shigeaki
Kume, Toshiyuki
论文数: 0引用数: 0
h-index: 0
机构:
Mitsubishi Tanabe Pharma Corp, Discovery Technol Labs, Toda, Saitama 3358505, JapanKitasato Univ, Sch Pharm, Minato Ku, Tokyo 1088641, Japan
Kume, Toshiyuki
Hirono, Shuichi
论文数: 0引用数: 0
h-index: 0
机构:
Kitasato Univ, Sch Pharm, Minato Ku, Tokyo 1088641, JapanKitasato Univ, Sch Pharm, Minato Ku, Tokyo 1088641, Japan
机构:
Southern Med Univ, Sch Biotechnol, Guangzhou 510515, Guangdong, Peoples R ChinaSouthern Med Univ, Sch Biotechnol, Guangzhou 510515, Guangdong, Peoples R China
Chen, Bohong
Zhu, Zhibo
论文数: 0引用数: 0
h-index: 0
机构:
Southern Med Univ, Sch Pharmaceut, Guangzhou 510515, Guangdong, Peoples R ChinaSouthern Med Univ, Sch Biotechnol, Guangzhou 510515, Guangdong, Peoples R China
Zhu, Zhibo
Chen, Min
论文数: 0引用数: 0
h-index: 0
机构:
Sun Yat Sen Univ, Sch Pharmaceut, Guangzhou 510515, Guangdong, Peoples R ChinaSouthern Med Univ, Sch Biotechnol, Guangzhou 510515, Guangdong, Peoples R China
Chen, Min
Dong, Wenqi
论文数: 0引用数: 0
h-index: 0
机构:
Southern Med Univ, Sch Biotechnol, Guangzhou 510515, Guangdong, Peoples R ChinaSouthern Med Univ, Sch Biotechnol, Guangzhou 510515, Guangdong, Peoples R China
Dong, Wenqi
Li, Zhen
论文数: 0引用数: 0
h-index: 0
机构:
Southern Med Univ, Sch Biotechnol, Guangzhou 510515, Guangdong, Peoples R ChinaSouthern Med Univ, Sch Biotechnol, Guangzhou 510515, Guangdong, Peoples R China